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Abstract
Background: Patients with metabolic syndrome, who are characterized by co-existence of insulin resistance,
hypertension, hyperlipidemia, and obesity, are also prone to develop non-alcoholic fatty liver disease (NAFLD).
Although the prevalence and severity of NAFLD is significantly greater in men than women, the mechanisms by
which gender modulates the pathogenesis of hepatic steatosis are poorly defined. The obese spontaneously
hypertensive (SHROB) rats represent an attractive model of metabolic syndrome without overt type 2 diabetes.
Although pathological manifestation caused by the absence of a functional leptin receptor has been extensively
studied in SHROB rats, it is unknown whether these animals elicited sex-specific differences in the development
of hepatic steatosis.
Methods: We compared hepatic pathology in male and female SHROB rats. Additionally, we examined key
biochemical and molecular parameters of signaling pathways linked with hyperinsulinemia and hyperlipidemia.
Finally, using methods of quantitative polymerase chain reaction (qPCR) and western blot analysis, we quantified
expression of 45 genes related to lipid biosynthesis and metabolism in the livers of male and female SHROB rats.
Results: We show that all SHROB rats developed hepatic steatosis that was accompanied by enhanced expression of
SREBP1, SREBP2, ACC1, and FASN proteins. The livers of male rats also elicited higher induction of Pparg, Ppara, Slc2a4,
Atox1, Skp1, Angptl3, and Pnpla3 mRNAs. In contrast, the livers of female SHROB rats elicited constitutively higher levels
of phosphorylated JNK and AMPK and enhanced expression of Cd36.
Conclusion: Based on these data, we conclude that the severity of hepatic steatosis in male and female SHROB rats
was mainly driven by increased de novo lipogenesis. Moreover, male and female SHROB rats also elicited differential
severity of hepatic steatosis that was coupled with sex-specific differences in fatty acid transport and esterification.
Background
Metabolic syndrome (MetS), a sequela characterized by
the co-occurrence of insulin resistance, hypertension,
hyperlipidemia, and obesity [1], is emerging as a major
public health challenge, affecting nearly one third of
adults in the USA of America [2]. Epidemiological studies
have clearly demonstrated that although both genetic and
environmental factors underlie the development of MetS,
its primary drivers are overconsumption of calorie-dense
foods and sedentary lifestyle. Clinical correlates of MetS
and its molecular underpinnings have been extensively in-
vestigated in rodent models such as ob/ob mice [3], db/db
mice [4], and fa/fa rats [5]. Although it is well known that
rodent models of MetS mimic the human syndrome to
varying degrees [6], studies in rodents have yielded crit-
ical evidence that mechanistically links hallmarks of
MetS (visceral adiposity, hyperglycemia, and hyperten-
sion), with mechanisms of nutrient partitioning and energy
homeostasis. Experimental animals have also played a cru-
cial role in unraveling the genetic, neuronal, and humeral
mechanisms involved in the control of food intake and
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energy metabolism and how their defective regulation leads
to MetS [7–10].
The obese spontaneously hypertensive (SHROB) rats,
also known as Koletsky rats, are thought to manifest the
essential traits that characterize the MetS [11]. The
SHROB rats were shown to be unique since they not
only elicited genetic hypertension similar to their lean,
spontaneously hypertensive (SHR) parents but also elicited
congenital obesity on regular chow diet. The genome of
SHROB rat harbors a nonsense mutation in codon 763 of
the gene encoding the leptin receptor [12]. SHROB rats
express normal amounts of mutated leptin receptor mes-
senger RNA that fails to be translated into functional lep-
tin receptors [13–15]. In the face of harboring two copies
of the defective leptin receptor gene, SHROB rats were
also shown to hyper-secrete leptin in their bloodstream.
Thus, besides being hypertensive, SHROB rats elicited
monogenetic obesity that was associated with hyperlipid-
emia, hyperinsulinemia, and striking proteinuria and renal
disease [11]. It is also noteworthy however, that although
SHROB rats were glucose intolerant compared with their
heterozygous or WT littermates, their fasting glucose
levels were normal even on a high-sucrose diet. Strikingly,
both male and female SHROB rats were infertile and
had a shorter lifespan, surviving only for 10–11 months
while their WT littermates had an average lifespan of
2–3 years [16, 17].
The prevalence and severity of non-alcoholic fatty liver
disease (NAFLD) in many populations around the globe
is higher in men than women [18–20]. Although some
gender-specific differences in the metabolism of dietary
glucose and fatty acids in humans have been reported
[21], how they differentially modulate the pathogenesis
of hepatic steatosis and NAFLD is far from clear [22].
SHROB rats are known to develop hepatomegaly and
fatty liver similar to many patients with MetS. Several
investigators have peered into the hormonal and bio-
chemical underpinnings of adiposity and MetS in SHROB
rats [23–25]. For instance, Ernsberger et al. observed
widespread deposition of fat in the SHROB rats but noted
that their retroperitoneal and subscapular adipose depots
were particularly prominent [26]. These authors also re-
ported that, in contrast to their SHR counterparts, the adi-
posity of SHROB rats was apparently affected by their sex;
they showed that while SHROB males accumulated nearly
12-fold higher amount of epididymal fat, the myometrial
fat depots in female SHROB rats were elevated by 19-fold.
Based on the rates of incorporation of labeled glucose into
lipids in various tissues (e.g., muscle, adipose tissue, and
liver), Ernsberger et al. surmised that obesity of SHROB
rats was mainly driven by de novo lipid synthesis [26].
Although these observations hinted at the possibility of
sexual dimorphism underlying the development of MetS,
its putative sex-specific consequences on the metabolism
of lipids in the liver of SHROB rats were not studied in
depth. To address this question, we examined the signal-
ing pathways canonically linked with hyperinsulinemia in
the livers of male and female SHROB rats. Additionally,
we compared the expression of a set of 45 candidate genes
that are known to be involved in sex-specific regulation of
the biosynthesis and metabolism of lipids. Our findings
corroborate and extend previous studies to indicate that
hepatic steatosis and its molecular mechanisms are indeed
differentially regulated in male and female SHROB rats.
Methods
Reagents
Anti-IRS-1, anti-pIRS-1 (S307), anti-AKT (T308), anti-
AKT, anti-p-mTOR (S2448), anti-mTOR, anti-p-p70S6K
(T389), anti-p70S6K, anti-p-S6 (S235/S236), anti-S6, anti-p-
p38MAPK (T180/Y182), anti-p38MAPK, anti-p-ERK1/2
(T202/Y204), anti-ERK1/2, anti-p-SAPK/JNK (T183/Y185),
anti-SAPK/JNK, anti-p-AMPK (T172), anti-AMPK, anti-
ACC1, and anti-FASN monospecific antibodies were pur-
chased from Cell Signaling (Danvers, MA). Insulin, Oil Red
O, and anti-actin antibodies were obtained from Sigma-Al-
drich (St. Louis, MO). Anti-SREBP1 antibody was bought
from Becton-Dickinson (Franklin Lakes, NJ). Anti-SREBP2
and anti-ChREBP antibodies were bought from R&D
Systems (Minneapolis, MN). Combined protease and
phosphatase inhibitor cocktails (Halt™) and Tissue-
Tek™ optimum cutting temperature (OCT) compound
were bought from Thermo Fisher Scientific (Hampton,
NH). Forward and reverse oligonucleotide primers
(Additional file 1: Table S1) to carry out quantitative
PCR analysis were designed according to a published
program (OligoArchitectTM online, Sigma-Aldrich,
St. Louis, MO). DNA primers were synthesized by In-
tegrated DNA Technologies (Coralville, IA).
Animal husbandry, genotyping, and laboratory studies
All animal procedures were approved by the Institutional
Animal Care and Use Committee (IACUC) of University
of Tennessee Health Science Center (UTHSC), Memphis.
Adult male and female heterozygous SHROB breeding
pairs were obtained from a closed colony that has been
continuously maintained since 1973 [26]. Since homozy-
gous rats are sterile, the SHROB strain was propagated by
mating age-matched heterozygous males and females. Rats
were housed in a room with a constant light and dark
cycle of 12-h each, at 20–23 °C. Animals had full access to
Teklad LM-485 mouse/rat chow (containing 17, 25, and
58% calories from fat, protein, and carbohydrate, respect-
ively), bought from Research Diets Inc. (New Brunswick,
NJ). Most experimental measurements, signal transduc-
tion, and gene expression analyses (western blot and
qPCR) were carried out on 10-week-old homozygous male
and female SHROB rats.
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Tail clip DNA samples, extracted using DNase Blood &
Tissue Kit (Qiagen, Hilden, Germany), were subject to
PCR with tetra-pair ARMS (amplification-refractory mu-
tation system) primers (Additional file 1: Table S1) that
were designed as described in detail (http://primer1.
soton.ac.uk/primer1.html). The PCR was done using
Thermo Scientific DreamTaq PCR Master Mix (2×) in
a SimpliAmp Thermal Cycler (Applied Biosystems by
Life Technologies, Foster City, CA). The PCR condi-
tions were 94°C for 3 min, 35 cycles of 94°C 1 min,
51.1°C 1 min, and 72°C 1 min, followed by extension
at 72°C for 10 min. DNA fragments containing codon
763 of the leptin receptor gene were amplified with
two outer primers (Additional file 1: Figure S1) and
purified by ExoSAP-IT™ PCR Product Cleanup Re-
agent from Thermo Fisher Scientific (Waltham, MA).
Amplified genomic DNA fragments were sequenced in
the Molecular Resource Center of the UTHSC, using
ABI Model 3130XL Genetic Analyzers (Foster City,
CA) with four-color fluorescence-based sequencing.
Body weight was measured weekly between weeks 3
and 10. Total fat mass and fat-free mass of WT and
homozygous SHROB rats were measured at week 10,
using a magnetic resonance imaging (MRI) machine,
EchoMRI-1100 (EchoMRI LLC, Houston, TX). Blood
was collected from 10-week-old rats via cardiac puncture,
and serum was obtained from clotted blood. Concentra-
tions of alanine aminotransferase (ALT), amylase, aspar-
tate aminotransferase (AST), blood urea nitrogen (BUN),
creatinine, cholesterol, glucose, and triglyceride in the sera
were determined by IDEXX BioResearch Laboratories
(Columbia, MO).
Western blot analysis
Protein extracts from homogenized livers were size-frac-
tionated by SDS-PAGE and transferred onto nitrocellu-
lose membranes that were probed with monospecific,
primary, and secondary antibodies as described previously
in detail [27]. Western blots were quantified using Quan-
tity One software from Bio-Rad (Hercules, CA).
Quantification of gene expression by qPCR
Three replicate liver samples, representing WTand SHROB
male and female rats, were used to extract total RNA using
Trizol reagent (Invitrogen, Carlsbad, CA). RNA was con-
verted into cDNA and subject to quantitative PCR (qPCR)
with gene-specific primers (Additional file 1: Table S1) and
GoTaq qPCR Master Mix (Promega, Madison, WI). PCR
amplification was carried out using a LightCycler 480
Real-Time PCR system (Roche, Basel, Switzerland). The
specificity of the qPCR amplification was verified by
melting curve analysis. Data were analyzed using the
ΔΔCT threshold cycle method. Target mRNAs were nor-
malized against Rn18s ribosomal RNA and fold changes in
experimental samples relative to those in control samples
were calculated [28].
Histology
Tissue samples fixed in 4% paraformaldehyde/PBS for
24 h and embedded in paraffin were cut into 5 μm sec-
tions. De-paraffinized liver sections were stained with
hematoxylin and eosin (H&E). Blocks of fresh liver tis-
sues were embedded in frozen OCT compound and
cryo-sectioned into 14-μm-thick slices; tissue sections
were stained with 0.3% Oil Red O for 5 min at room
temperature to visualize intracellular accumulation of
lipid droplets [29]. The Oil Red O staining of tissue sec-
tions was quantified using the ImageJ software (NIH,
Bethesda, MD).
Extraction and measurement of triglyceride content in
liver tissue
Measurements of hepatic TG content were done exactly
as outlined in detail previously [30]. Fragments of frozen
liver were taken up in homogenization buffer (50 mM
Tris, pH 8, 5 mM EDTA, 30 mM mannitol, and cocktail
of protease inhibitors) and lysed using a TissueLyser II
(Qiagen). Total lipids were extracted with 250 mM KOH
and a mixture of chloroform and methanol (2:1). Liver
tissue extracts were centrifuged at 13,000 × g for 10 min.
As described by Lu et al. [30], the bottom layer was
dried and taken up in a mixture of 3 mL butanol,
1.66 mL Triton X-114, and 0.33 mL methanol, and TGs
were quantified using the Sigma Triglyceride Assay Kit
(Cat TR0100, Sigma-Aldrich).
Statistical analysis
Means ± SEM were derived from 3 to 5 experiments (as
indicated in the figure legends). A two-way analysis of
variance (ANOVA) was performed to assess statistically
significant differences between groups, using GraphPad
Prism 6.0 software (La Jolla, CA). p values of < 0.05 were
considered to be statistically significant. Putative interac-
tions between genotype and gender were similarly exam-
ined by two-way ANOVA measurements.
Results
Genotyping of SHROB rats
SHROB rats were genotyped using a strategy based on
PCR amplification of genomic DNA followed by its se-
quencing (Additional file 1: Figure S1a and b). We de-
signed four PCR primers to amplify a region of the
leptin receptor genomic DNA that included T > A muta-
tion that leads to premature termination of translation
in the leptin receptor mRNA [13]. Amplification of the
genomic DNA by PCR using flanking primers should
yield a 248-bp DNA fragment regardless of the genotype
whereas two internal primers should yield 184-bp and
Dong et al. Biology of Sex Differences  (2018) 9:40 Page 3 of 15
118-bp fragments representing WT or SHROB alleles,
respectively (Additional file 1: Figure S1a). As expected,
genomic DNA of heterozygous rats produced three frag-
ments, 248-bp, 184-bp, and 118-bp in length; in contrast,
PCR amplification of homozygous SHROB genomic DNA
produced 248-bp and 118-bp bands (data not shown). Se-
quencing of DNA around codon 763 of the leptin receptor
gene unequivocally identified the genotypes of the WT,
heterozygous, and homozygous rats (Additional file 1:
Figure S1b).
Gender-specific differences in body mass and liver size in
SHROB rats
We assessed rates of growth and body composition of
female and male SHROB rats fed with a regular chow
diet, between the ages of 3 and 10 weeks. As reported
originally [11], the obese phenotype is recessive, and the
gross morphology of heterozygous (Fak/fak) rats did not
differ significantly from WT. Therefore, in our study, all
comparisons were made either between WT and homo-
zygous (fak/fak) SHROB rats or between SHROB (fak/fak)
males and females. A representative WT and SHROB fe-
male and male rats at 10-week of age are shown in
Fig. 1a. Body weights of 3-week-old rats, irrespective of
their genotypes, were very similar. Additionally, although
all animals steadily grew bigger over a period of 7 weeks,
the growth curve of the SHROB male rats was the stee-
pest among the four groups of animals; in contrast, WT
females elicited the lowest rates of body mass gain
(Fig. 1b). At week 10, males were visibly bigger than fe-
males (Fig. 1a–c).
Next, we measured relative changes in the total body
fat and lean masses of WT and SHROB rats at week 10.
Compared with WT rats, the fat mass of female and
male SHROB rats was increased by 10.8- and 6.5-fold,
respectively (Fig. 1d). Although, total fat mass of male
SHROB rats was higher versus homozygous females
(Fig. 1d), when expressed as percentage of body weight,
fat mass increased to comparable levels in male and fe-
males (Fig. 1e). Moreover, although lean mass for both
male WT and SHROB rats were higher than correspond-
ing females, 10-week-old male SHROB rats lost significant
lean mass compared to WT. In contrast, 10-week-old
SHROB females gained lean mass compared with their
WT female littermates (Fig. 1f). We should also note that
at week 10, percent lean mass in both male and female
SHROB rats was significantly decreased compared with
WT rats, respectively (Fig. 1g). The results of two-way
ANOVA (Figs. 2d–g) indicated that both genotype and
gender contributed to age-dependent changes in fat mass,
percent body fat, lean mass, and percent lean mass of
SHROB rats fed a regular chow diet.
Visible gender-specific differences in the sizes of bod-
ies of SHROB rats corresponded with the sizes of their
livers (Fig. 2a, b). We also noted that although livers of
both female and male SHROB rats grew bigger at week
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10, the livers of male rats were larger and paler in appear-
ance (Fig. 2a). The apparent disparity in sizes of livers be-
tween male and female SHROB rats remained highly
significant even after the normalization of their liver
weights against body weights (Fig. 2c). These data revealed
that, as expected, the livers of male SHROB rats were con-
siderably larger than their male WT littermates. Even
more significantly, the livers of male SHROB rats were
even bigger and paler than those of SHROB females
(Fig. 2a–c). To assess the underlying biochemical basis of
differential gross morphology (more lipid droplets), we
measured hepatic TG content in these animals. As shown
in Fig. 2d, the livers of male SHROB rats had ~ 6-fold
greater amount of TG compared with females (Fig. 2d).
To assess if gender-specific differences in gross morph-
ology of male SHROB rats and their livers were related to
putative changes in hepatic tissue architecture, we sec-
tioned the livers from male and female SHROB rats and
stained these with H&E and Oil Red O. As shown in
Fig. 2e, H&E-stained sections of livers from male SHROB
rats appeared highly vacuolated (denoting areas of lipid
droplets accumulation, as judged by Oil Red O staining).
Lipid-laden hepatocytes were more prevalent in the peri-
central areas of the liver as opposed to periportal areas
(Fig. 2e). Thus, Oil Red O staining revealed that although
some hepatic steatosis was evident in all SHROB rats (un-
like WT animals) regardless of their gender (Fig. 2f),
SHROB males elicited more severe steatosis as judged by
accumulation of lipid droplets (Fig. 2f). Quantification of
lipid droplets confirmed the visual impression to reveal
disproportionately greater accumulation of fat in the livers
of male SHROB rats (Fig. 2g). We should note however,
that in spite of the differences in the hepatic histology of
male and female SHROB rats, H&E staining did not reveal
signs of overt fibrosis (Fig. 2e; data not shown). However,
these data led us to tentatively conclude that both geno-
type and gender contributed to the severity of hepatic
steatosis in SHROB rats.
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Biochemical analysis of serum in female and male
SHROB rats
We analyzed the serum of male and female SHROB rats
for markers of hepatic inflammation, pancreatic and kid-
ney functions, and circulating lipids. As shown in Fig. 3,
the levels of AST, creatinine, and glucose were very simi-
lar in all groups of rats. Compared to WT rats, serum
ALT levels were 1.7-fold and 2.4-fold higher in female
and male SHROB rats, respectively (Fig. 3b).
The amylase index for both male WT and male SHROB
rats was higher than the respective females (Fig. 3c). Com-
pared with WT rats, the levels of BUN were greater in
both male (~ 34%) and female (~ 48%) SHROB rats
(Fig. 3d). In 10-week-old rats, there were small but insig-
nificant changes in the levels of creatinine and glucose;
these animals have been shown to develop proteinuria
and renal disease in later life [11]. Both male and female
SHROB rats had hypercholesterolemia compared with
WT rats (Fig. 3g). The levels of TGs in circulation in fe-
male SHROB rats were ~ 8-fold higher compared to WT
females. We should note however, that serum TGs were
only 1.85-fold higher in the SHROB males (Fig. 3h). Com-
pared with their WT littermates, hyperinsulinemia was
evident in both male and female SHROB rats, with circu-
lating levels of insulin being 14.1-fold and 11.5-fold higher,
respectively (Fig. 3i).
Insulin pathway is differently influenced for female and
male SHROB rats
Since both hyperinsulinemia and hepatic steatosis were
more pronounced in male SHROB rats, we investigated
if insulin signaling pathways were differentially impaired
in males and females. It has been documented previously
[26] that the skeletal muscle and livers of SHROB rats had
lower levels of total and phosphorylated insulin receptor
substrate 1 (IRS-1). Consistent with earlier reports, we
noted that levels of IRS-1 in the livers of SHROB rats were
significantly lower (Fig. 4). IRS-1, a key target of insulin re-
ceptor kinase, contains more than 30 potential serine/
threonine phosphorylation sites; while phosphorylation of
some sites (e.g., Y895, Y1222) is associated with activation
of IRS-1, phosphorylation of others (e.g., S307) disrupts
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IRS-1/insulin receptor interaction [31–33]. As shown in
Fig. 4, hepatic extracts of male SHROB rats had higher
steady-state levels of IRS phosphorylated at S307, reflecting
an impairment of insulin signaling.
IRS-1 phosphorylates and activates PI3 kinase that gen-
erates PIP3 and activates the 57-kDa Ser/Thr kinase AKT
(also known as protein kinase B, PKB) via phosphorylation
at T308. As judged by pAKT (T308) levels in the hepatic
extracts of SHROB females (Fig. 4), they elicited greater
insulin sensitivity compared with their male counterparts.
We should note however, that despite gender-specific dif-
ferences seen in the proximal steps of insulin signaling
pathway, the downstream activation of the mTOR (mech-
anistic target of rapamycin) signals was apparently elicited
in a gender-neutral fashion. Thus, we did not observe sig-
nificant differences in the constitutive levels of total or
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phosphorylated mTOR, p70S6K, and S6K in the liver ex-
tracts obtained from male and female SHROB rats (Fig. 4).
Crosstalk between PI3K-AKT/PKB and MAPK signaling
is known to be significantly altered during hyperinsulinemia
[34]. Therefore, we assessed putative changes in the activa-
tion of MAPK pathways and their downstream conse-
quences for hepatic gene expression in female and male
SHROB rats (Fig. 5). We discovered that SHROB rats of
both genders had higher levels of p-p38MAPK (phosphory-
lated at T180/Y182) and p-ERK1/2 (phosphorylated at
T202/Y204) compared to their respective WTcounterparts.
In contrast, hepatic extracts of female SHROB rats had
higher constitutive levels of activated SAPK/JNK, phos-
phorylated at T183/Y185 (Fig. 5).
Since the canonical PI3K-AKT/PKB and MAPK sig-
naling pathways culminate in the nucleus by inducing a
program of gene expression relegated to de novo lipid
synthesis and gluconeogenesis, we quantified expression
of a subset of metabolic regulators by western blot analysis,
followed by densitometry (Fig. 6). These experiments re-
vealed that the steady-state levels of proteins involved in de
novo lipid biosynthesis (pSREBP1, nSREBP1, ACC1, and
FASN) were expressed more abundantly in the livers of
SHROB rats. We also noted however, that female SHROB
rat livers elicited greater expression of pSREBP2, nSREBP2,
p-AMPK, and AMPK (Fig. 6). In contrast, the expression of
ChREBP (carbohydrate response element-binding protein),
a key transcription factor involved in de novo lipid syn-
thesis [35, 36] was more abundantly expressed in the
livers of SHROB males. Interestingly, the steady-state
levels of total and phosphorylated AMP-activated pro-
tein kinase (AMPK) were higher in the livers of SHROB
females (Fig. 6).
Quantification of gene expression by qPCR in WT and
SHROB rats
To further investigate the putative molecular basis of
sexual dimorphism in hepatic lipid metabolism in
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SHROB rats, we assessed the mRNA levels of a panel of
45 genes shown previously to be differentially regulated
in males and females [37]. As shown in Fig. 7, the ex-
pression of Pparg, Ppara, Slc2a4, Atox1, Skp1, and
Angptl3 genes was moderately increased in the female
SHROB rats; however, these animals elicited much
greater expression of Cd36 compared with SHROB
males. Moreover, although steady-state levels of mRNAs
encoded by Srebf1, Acaca, Scd, Fasn, and Acly were in-
creased in both male and females, and their expression
was significantly greater in males; a ~ 500-fold induction
of Pnpla3 expression in SHROB males was particularly
notable (Fig. 7).
The four cardinal features of MetS in humans, insulin
resistance, visceral adiposity, severe dyslipidemia, and
endothelial dysfunction are often associated with sys-
temic inflammation [6]. Therefore, we investigated if ex-
pression of canonical pro-inflammatory genes (e.g., Tnf,
IL-1b, Il-6, and Ccl2) in the livers of male and female
SHROB rats were differentially affected. As judged by
the results of qPCR, none of the target genes showed
gender-associated differential expression of the livers of
WT or SHROB rats (data not shown).
Discussion
Non-alcoholic fatty liver disease (NAFLD) is frequently
associated with MetS [38]. The initial stage of NAFLD is
hepatic steatosis, which may progress to non-alcoholic
steatohepatitis [38] and eventually hepatocellular carcin-
oma [39]. Both epidemiological and animal studies
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indicate that the prevalence of NAFLD is higher in
males [21, 40, 41]. However, the underlying mechanistic
basis of sex-specific differences of hepatic steatosis and
its clinical consequences are poorly understood.
The SHROB (fak/fak) shows several features of human
MetS [6] that include obesity, hyperinsulinemia, hyperlip-
idemia, and genetically encoded hypertension [23, 24, 26].
Although hormonal and biochemical underpinnings of
MetS have been extensively analyzed in SHROB rats,
here, we show for the first time that there are gender-
specific differences in the development of hepatic
steatosis in these animals. Additionally, we show that
hyperinsulinemia-induced signaling pathways and a
panoply of hepatic genes involved in lipid biosynthesis
and metabolism are differentially regulated in male and
female SHROB rats.
Consistent with earlier reports, insulin signaling
pathways were significantly blunted in SHROB rats,
regardless of gender. Nevertheless, SHROB females were
significantly more insulin-sensitive. Additionally, we noted
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gender-specific differences in phosphorylation-dependent
activation of p38MAPK, ERK1/2, and SAPK/JNK. The
MAPK pathway is characterized by a 3-tier sequential
activation of MAPK kinase kinase (MKKK), MAPK kinase
(MKK), and MAPK. Extracellular stimuli trigger the
MKKK and its downstream cascade of kinases via protein-
protein interactions, phosphorylation, and subcellular
compartmentalization [34]. The MAPK signaling cas-
cades impinge on transcription factors like ELK-1 [42],
PPARγ 2 [43], and SREBPs [44] that regulate gene net-
works involved in energy homeostasis. Kotzka et al. have
shown that the N-termini of SREBP-1a, SREBP-1c, and
SREBP-2 are phosphorylated by ERK, JNK, and p38 MAPK
[45–48]. The importance of MAPK-mediated phosphoryl-
ation of SREBP-1 in pathophysiology of MetS in humans
was bolstered by the finding of a rare allele of SREBP-1,
defective in serine 117 phosphorylation by ERK and
JNK. Patients carrying this mutation elicited severe
combined hypolipidemia [49]. Thus, SREBPs converge
at the regulatory nexus of insulin resistance, obesity,
and inflammation, all of which are subject to regulation
by MAPK [50].
Quantification of expression of 45 genes that may con-
tribute to gender-specific differences in hepatic steatosis
[37] revealed a rather complex picture of hepatic lipid me-
tabolism in SHROB rats. Thus, genes encoding Srebf1,
Acaca, Scd, Fasn, and Acly were highly induced in the
livers of SHROB rats. However, with the exception of
Acaca, all were similarly induced in the livers of males and
females. In contrast, expression of seven genes (Pparg,
Cd36, Slc2a4, Atox1, Skp1, Angptl3, and Pnpla3) showed
a gender-specific bias. The aberrant expression of PPARγ
[51] is associated with NAFLD [52–54], and liver-specific
loss of PPARγ is known to markedly attenuate the patho-
genesis of NAFLD [55, 56]. The PPARγ activates SREBP-
1c, a master transcription factor that promotes de novo
lipid synthesis [57]. PPARγ2 and C/EBPα cooperate to ac-
tivate transcription of many adipocyte specific genes [58].
We posit that more enhanced expression of PPARγ in
males versus females is mechanistically involved in differ-
ential regulation of hepatic steatosis in SHROB rats.
PPARα stimulates β-oxidation of fatty acids; PPARα li-
gands trigger SCD1 activity which is necessary for VLDL
secretion [59].
The livers of male SHROB rats expressed lower levels of
the Cd36 gene, consistent with their genetic derivation
fromWistar Kyoto (WKR) strain [26, 60]. CD36 protein be-
longs to the class B scavenger receptor family [61] and
binds to native and oxidized low-density lipoproteins [62]
and long-chain fatty acids [63]. The Cd36 receptor pro-
motes fatty acid uptake into muscle and adipose tissues
[64–66]. Deficiency of Cd36 in SHR rats, shown to be asso-
ciated with insulin resistance [67, 68], could be corrected
by exogenously expressed Cd36 [69]. Hyperlipidemia and
insulin resistance have been reported in Cd36-deficient
mice [70, 71] and humans [61]. Expression of Slc2a4 was
higher in male SHROB rats putatively causing greater influx
of glucose, thus accelerating its flux into the Krebs cycle.
Therefore, we posit that enhanced influx of glucose and
fatty acids into the livers of male SHROB rats led to more
de novo lipid biosynthesis.
All SHROB rats elicited an enhanced expression of
Pnpla3, but its ~ 500-fold induction in the livers of male
rats was remarkable. Pnpla3 encodes a nonspecific lipid
acyl hydrolase that is highly expressed in the liver and
adipose tissue [72]. Ninety percent of Pnpla3 in hepato-
cytes is associated with lipid droplets [73]; the mechan-
ism by which Pnapla3 regulates lipid droplet biogenesis
remains controversial [74]. Expression of Pnpla3 is
highly induced by carbohydrate feeding and insulin [75].
The promoter of murine Pnpla3 gene contains consen-
sus binding sites for ChREBP and SREBP-1c [76, 77].
Therefore, it is highly likely that enhanced accumulation
of lipid droplets in the livers of SHROB males may be a
direct result of elevated expression of ChREBP and
SREBP-1c that transcriptionally activated the Pnlpa3
gene.
The expression of Atox1 and Skp1 mRNA was higher
in male SHROB rats than female SHROB rats. Induc-
tion of Atox1 and Skp1 has been associated with high
levels of TGs in liver and adipose tissue [37]. Skp1α is a
component of SCF complex that plays a key role in
hepatic lipid accumulation [78]. Hepatic expression of
the angiopoietin-like protein 3 (Angptl3) mRNA was
also higher in SHROB males. ANGPTL3 is a member of
a family of secreted glycoproteins structurally related to
angiopoietins that regulates lipid, glucose, and energy
metabolism [79–81]. ANGPTL3 is highly expressed in
the liver and acts in concert with LXR [80, 82]. The
livers of db/db mice expressed high levels of Angptl3
[83] that could be normalized by leptin treatment [84].
Conversely, targeted deletion of Angptl3 leads to lower
plasma TG and cholesterol [85]. Inactivating mutations
in the ANGPTL3 gene cause familial combined hypoli-
pidemia, a disorder characterized by profound reduc-
tion of plasma lipoproteins [86]. Disabling ANGPTL3
with antisense oligonucleotides or antibodies also
lowers plasma TG and LDL cholesterol in humans [87].
Conclusion
We have corroborated and extended previous observa-
tions to conclude that hepatic steatosis in SHROB rats,
regardless of their gender, is driven mainly by higher
rates of de novo lipogenesis that occur in a setting of
conspicuous absence of hyperglycemia [23, 24, 26].
Additionally, our data indicated that female SHROB
rats elicited more efficient fatty acid transport (Cd36)
and esterification (Pnpla3), and greater insulin sensitivity
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(higher phosphorylation of AKT and AMPK), all of which
contributed to less severe steatosis. Differential regulation
of AMPK in male and female SHROB rats is of great
interest since AMPK is known to improve insulin sensitiv-
ity by decreasing de novo lipogenesis as well as enhancing
both fatty acid oxidation and mitochondrial integrity [88].
A number of recent studies have suggested that a combin-
ation of reduced fatty acid oxidation and enhanced rates
of de novo lipogenesis might be mechanistically related to
differential pathogenesis of NAFLD in humans [21]. Our
tentative conclusion must be further moderated by two
major caveats. First, the hepatic steatosis in SHROB rats
only partially mimics the hepatic consequences of human
MetS in light of the dissimilarities in the biology of
leptin in rodents and man, where unequivocal involve-
ment of leptin receptor in hepatic steatosis has yet to
be demonstrated. Second, an explanation for an appar-
ent lack of markers of overt inflammation and fibrosis,
with concomitant induction of SAPK/JNK, in the
livers of SHROB rats is puzzling and must await future
investigation.
Perspectives and significance
Sex-specific differences in hepatic steatosis, differential
regulation of hyperinsulinemia-associated signaling
pathways, and canonical genes involved in lipid metab-
olism in male and female SHROB rats, outlined here,
are highly significant. SHROB rats are hypogonadal,
caused by the loss of leptin signaling and a consequen-
tial reduction in luteinizing hormone-releasing hor-
mone (LHRH) in the hypothalamus [11, 89]. The
prevalence of NAFLD is higher in men with hypogo-
nadism as well in post-menopausal women [90]. How-
ever, our hypothetical scenario explaining these data
(Fig. 8) provides only a glimpse into the mechanisms
involved in hepatic steatosis and its modulation by
gender. This mechanistic picture will be considerably
sharpened by more comprehensive, genome-wide ana-
lyses of hepatic gene expression, using “omics” techniques
[91]. Finally, a clear-cut relevance of experimental findings
in SHROB rats to gender-specific differences in NAFLD
in humans remains murky, particularly in the absence
of overt inflammation and fibrosis in this model. A re-
cent report showing that pro-inflammatory responses
associated with NAFLD pathogenesis could be exacer-
bated if mice were housed at their body temperature
rather than kept in a conventional, ambient tempe-
rature housing [92]. Thus, under thermo-neutral condi-
tions, fatty diet-induced hepatic steatosis was exacerbated
in a gender-specific manner in several strains of mice. The
notion of temperature-mediated modulation of the patho-
genesis of NAFLD in SHROB rats needs to be experimen-
tally tested.
Additional file
Additional file 1: Figure S1. Genotyping of SHROB rats. A: Design of
tera-pair primers to amplify leptin receptor region including the T>A mu-
tation by PCR and the resulting sizes of DNA fragments in WT (248-bp
Fig. 8 Hypothetical scheme showing major steps involved in sex-
specific differences in the pathogenesis of hepatic steatosis in
SHROB rats. Both female and male SHROB rats elicit hyperphagia,
hyperinsulinemia, and hyperlipidemia. Activation of hyperinsulinemia-
induced signaling pathways leads to induction of genes that regulate
de novo lipogenesis. Several genes that control lipid metabolism are
highly expressed in male and female SHROB rat livers. Expression of
Cd36 and Pnpla3 genes was differentially regulated in female and male
SHROB rats, leading to milder and severe hepatic steatosis, respectively
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and 184-bp), heterozygous (248-bp, 184-bp, and 118-bp) and homozy-
gous (248-bp and 118-bp) are shown. B: An example of targeted sequen-
cing around the mutated base (blue line) from the WT, heterozygous and
homozygous genomes are shown. Table S1. Primers used in this study.
(PDF 1101 kb)
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